Therapeutic Asset Ratings
1,482 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Hematopoietic And Lymphoid System Neoplasm
Cancer Research UK
P2/3
BB
(66)
Immunoglobulin G1 [de-449-lysine], anti-(human tau protein) (human-Mus musculus monoclonal E2814 ?1-chain), disulfide with human-Mus musculus monoclonal E2814 .kappa.-chain, dimer
Alzheimer Disease
Eisai Inc.
P2/3
BB
(66)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
Mayo Clinic
P2/3
BB
(66)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
Mayo Clinic
P2/3
BB
(66)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Intravascular Large B-Cell Lymphoma
Mayo Clinic
P2/3
BB
(66)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Mature B-Cell Lymphoma
BeOne Medicines
P2/3
BB
(66)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Acute Myeloid Leukemia
University Hospital Tuebingen
P2/3
BB
(66)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Myelodysplastic Syndrome
University Hospital Tuebingen
P2/3
BB
(66)
Inno-206
Primary Peritoneal Serous Adenocarcinoma
National Cancer Institute (NCI)
P2/3
BB
(66)
Letrozole
Micropapillary Serous Carcinoma
Gynecologic Oncology Group
P2/3
BB
(66)
Losartan
Cognitively Normal Older Adults
Rong Zhang
P2/3
BB
(66)
Losartan
Subjective Cognitive Decline
Rong Zhang
P2/3
BB
(66)
Nivolumab
Non-Hodgkin Lymphoma
University of Pittsburgh
P2/3
BB
(66)
Nivolumab
Myelodysplastic Syndrome
SCRI Development Innovations, LLC
P2/3
BB
(66)
Pentoxifylline
Peripheral Neuropathy
Tanta University
P2/3
BB
(66)
Recombinant Human Serum Albumin
Cirrhotic Ascites
Protgen Ltd
P2/3
BB
(66)
Regorafenib
Glioblastoma
Istituto Oncologico Veneto IRCCS
P2/3
BB
(66)
Romidepsin
Adult Acute Lymphoblastic Leukemia
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
P2/3
BB
(66)
Thalidomide
Beta Thalassemia
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
P2/3
BB
(66)
Venetoclax
Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P2/3
BB
(66)
VITAMIN D
Craniocerebral Trauma
Lagos State University
P2/3
BB
(66)
Azacitidine
Disease Related To Hematopoietic Stem Cell Transplant
The First Affiliated Hospital of Soochow University
P2/3
BB
(65)
Azacitidine
Myelodysplastic Syndrome/Acute Myeloid Leukemia
City of Hope Medical Center
P2/3
BB
(65)
Benadryl
Breast Carcinoma
Ohio State University Comprehensive Cancer Center
P2/3
BB
(65)
Blinatumomab
B-Cell Non-Hodgkin Lymphoma
Children's Hospital Medical Center, Cincinnati
P2/3
BB
(65)
Showing 151 to 175 of 1,482 assets
Previous
Page 7 of 60
Next
